Focus on win-win: BIPS 2nd Global Biomedical Innovation Pioneer China Summit 2022

Conference introduction

▪ The "2nd Global Biopharma Innovation Pioneer China Summit 2022" hosted by Cover Media Group will be held in Shanghai from May 26th to 27th, 2022
.

Guest starting lineup (part)

agenda

Biomedical R&D Innovation Pioneer Forum of BIPS2022 Series Summit

Antibody Drugs and Small Molecule Targeted Drugs
1: Development Progress and Future Prospects of PD-1/PD-L1 Antibody Drugs in the World and China
2: Development Strategy and Clinical Progress of Bispecific Antibody Antitumor Drugs
3: Unmet Market Demand Development of New First-in-class Antibody Drugs
4: Innovative R&D of ADC Drugs for Targeted
Tumor
Therapy
Application Trends in Tumor Treatment: Anti-vascular Targeted Drugs + Immunotherapy
Cell
and Gene Therapy: The Future 1: Clinical Research on Cell and Gene Therapy, Industry Status and Future Trend
2: Universal CAR-T and Dual-target CAR-T Research and development and clinical progress of T cell therapy
3: Research and development progress of tumor mRNA vaccine
4: Research progress of TCR-T cell immunotherapy in the treatment of solid tumors
5: Oncolytic virus combination therapy
6: Development and development of gene therapy drugs based on viral vectors Clinical Progress
Roundtable Discussion: Innovation and Prospect of Cell and Gene Therapy Technology in 2022
Companion Diagnostics Enables Drug Development
1: Strategies and Trends of Clinical Companion Diagnostics in New Drug Development
2: Strategies of Biomarkers and Companion Diagnostics in Targeted Drug Development
3: Strategies and challenges for co-development of new drug R&D and companion diagnostics
4: Second-generation sequencing technology NGS enables new tumor drug R&D and clinical treatment
5: Application and prospect of high-throughput single-cell sequencing analysis platform in innovative drug R&D
6:
Roundtable Discussion on Technological Breakthroughs and Commercialization Model Innovation in Early Tumor Screening : A New Collaborative Business Model in Drug-Diagnostic Co-
development
1: Multi-omics data analysis using machine learning
2: End-to-end AI drug development
3: AI-enabled compound synthesis screening
4: Synthetic biology and AI-assisted gene therapy drug development
5: The role of AI in macromolecular drug development Application:
6: Application of intelligently designed antibody technology in the development of tumor immune drugs
Roundtable Forum: AI Drug Development: Technology, Cases, Market Status and Future Prospects

Biopharmaceutical Process Innovation Pioneer Forum of BIPS2022 Series Summit

Innovation in China's biopharmaceutical industry: Biopharmaceutical 4.

Past Years Review

Site of previous sessions

To register, scan the QR code below

Media and conference affairs:
miranda@covermediagroup.

Sponsor, Speech:
terry@covermediagroup.

Conference co-organizer:
Caijiandao Peptide Network

Conference Strategic Media:
Analysis and Test Encyclopedia Network Chengma Health Network, Meibo Medical Health

Conference media cooperation (part):
Medical Geography, Pharmaceutical Online, Medical Device Innovation Network, Biological Device Network, Biological Exploration, Huihui Medicine Cafe, Medicine Ark, Chemistry+, Pharmaceutical Network, Arterial Network, Peptide Research Institute, Lusen Scientific Research, Biological latitude and longitude, new biological thinking, tumor immunotherapy information, Yaolu, biological medicine CMC, Xinkangjie, all the way to the north (medical community), Yaozhi.

Follow the official account for more information